• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hikal Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Kalyani
  • BSE Code : 4401.0
  • ISIN : INE475B01022
399.45 -6 (-1.38%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    394.60

  • Today’s High

    409.10

  • Open

    405.05

  • Perv Close

    405.05

  • 52W Low

    262.40

  • 52W High

    464.75

Key Indicators

  • P/E(TTM)

    66.24

  • Mar.Cap (₹Cr.)

    4,925.25

  • Div & Yield %

    0.30

  • Book Value(₹)

    97.59

  • Debt-Equity Ratio

    -1.38

  • AGM Date

    28-Mar-2025

  • EPS

    6.04

  • P/E Ratio

    66.24

Financials Ratios

  • Debt-Equity Ratio

    0.67

  • Mar.Cap (₹Cr.)

    4,925.25

  • RONW (%)

    6.00

  • ROCE (%)

    7.51

Score Board

  • Equity (₹ in Cr.)

    24.66

  • BV (₹)

    97.60

  • Sales( ₹ in Cr.)

    1,784.60

  • NP (in Cr.)

    69.14

  • NP Var(%)

    -11.0

  • Div%

    60.0

  • CPS (₹)

    15.10

  • EPS (₹)

    5.60

  • Traded Value (₹ in Lakhs)

    4,933.26

  • 52 Week High

    464.75

  • 52 Week Low

    262.40

  • Price BSE

    400.0

  • Price NSE

    399.00

  • Market Capital( in Cr.)

    4,933.26

  • P/C Ratio

    26.40

  • P/E Ratio

    71.30

  • Price Vs.BV

    5.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61
Excise Duty 1,745.40 1,988.62 1,901.77 1,700.99 1,457.27 1,562.03
Net Sales 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61
Other Income 2.45 5.41 4.89 4.98 3.70 2.26
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,787.05 2,028.44 1,947.61 1,725.42 1,510.97 1,591.87
EXPENDITURE :
Raw Materials 1,745.40 1,988.62 1,901.77 1,700.99 1,457.27 1,562.03
Power & Fuel Cost 1,745.40 1,988.62 1,901.77 1,700.99 1,457.27 1,562.03
Employee Cost 243.98 220.40 201.35 164.32 156.57 135.69
Other Manufacturing Expenses 26.10 27.02 21.28 21.71 21.95 27.19
Selling & Administrative Expenses 116.24 110.01 101.31 64.05 55.56 52.50
Miscellaneous Expenses 26.10 27.02 21.28 21.71 21.95 27.19
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,691.63 1,923.08 1,729.04 1,518.99 1,368.98 1,442.79
Operating Profit 306.68 301.50 281.82 239.09 223.70 222.29
Interest 56.37 48.10 31.22 36.20 52.42 58.43
Gross Profit 95.41 105.36 218.57 206.43 126.58 149.09
Depreciation 117.61 109.01 95.67 85.25 82.46 92.88
Profit Before Tax 95.41 105.36 218.57 206.43 126.58 149.09
Tax 28.37 30.48 59.65 79.55 34.70 45.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.47 -3.49 -1.59 -6.27 7.44 0.51
Reported Net Profit 69.51 78.38 160.51 133.14 84.44 103.08
Extraordinary Items 95.41 105.36 218.57 206.43 126.58 149.09
Adjusted Net Profit 69.51 78.38 160.51 133.14 84.44 103.08
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 14.80 14.80 19.73 24.66 14.80 14.80
P & L Balance carried down 69.51 78.38 160.51 133.14 84.44 103.08
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 60.00 60.00 80.00 100.00 60.00 60.00
Dividend Per Share(Rs) 1.20 1.20 1.60 2.00 1.20 1.20
Earnings Per Share-Unit Curr 5.64 6.36 13.02 10.80 6.85 8.36
Book Value 14.80 14.80 19.73 24.66 14.80 14.80
Book Value(Adj)-Unit Curr 14.80 14.80 19.73 24.66 14.80 14.80

Shareholding Pattern

  • Promoter Group

    68.85%

  • Public Share Holding

    31.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 72,172,664 58.53 72,172,664 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,895,100 9.65 11,895,100 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 825,000 0.67 825,000 8
Others 0 0.00 0 0
Sub Total 84,892,764 68.85 84,892,764 22
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,469,461 6.06 7,469,461 79
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,604,618 2.92 3,604,618 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 687,047 0.56 687,047 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,761,376 9.54 11,761,376 92
2] Non Institution
Bodies Corporate 2,050,681 1.66 2,050,681 375
Clearing Members 3,696 0.00 3,696 7
Directors of their Relatives 448,753 0.36 448,753 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,949,611 1.58 1,949,611 1,419
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,064,966 0.86 1,064,966 1,346
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,561,579 2.08 2,561,579 8
Individuals holding nominal share capital up to Rs. 1 lakh 17,961,084 14.57 17,827,872 68,471
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,515 0.02 18,515 2
Others 393,201 0.32 393,201 6
Sub Total 26,646,610 21.61 26,513,398 71,687
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 123,300,750 100.00 123,167,538 71,801

Company Background

Hikal LtdPharmaceuticals - Indian - Bulk Drugs

  • Hikal Ltd
  • BSE Code : 4401.0
  • ISIN : INE475B01022

  • Incorporation Year

    1988

  • Registered Office

    717/718 Maker Chamber V
    7th Floor Nariman Point, Mumbai,
    Maharashtra-400021

  • Telephone

    91-022-3926 7100/62770477

  • FAX

    91-022-2283 3913

  • Chairman

    Jai Hiremath

  • Managing Director

    Sameer Hiremath

  • Company Secretary

    Rajasekhar Reddy

  • Auditor

    S R B C & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Hikal Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hikal 400.10 1,787.05 1,784.60 66.24 7.51
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92